Hurone AI Founder Champions AI-Driven Cancer Solutions at SCHD25

Dr. Kingsley Ndoh, founder of Hurone AI and a leader in global health innovation, took on a pressing question at the 2025 Summit on Cancer Health Disparities (SCHD25) in Seattle: Can artificial intelligence and international collaboration close the gap in cancer care?

On April 26, 2025, Dr. Ndoh joined oncology professionals, researchers, policymakers, and other stakeholders to examine strategies for improving cancer outcomes and addressing equity gaps through emerging technologies and evidence-based practices. SCHD is an annual continuing medical education event organized by a global oncology nonprofit, Binaytara. This event focuses on reducing cancer care disparities and exploring how to bring the latest medical advances into everyday patient treatment.

At the summit, Dr. Ndoh chaired Session 7, Leveraging Technology and AI to Support Cancer Health Equity, which featured distinguished speakers including Dr. Chung Il Wi of the Mayo Clinic, Dr. Hoifung Poon of Microsoft Health Futures, and Dr. Helen Storey from PATH.

(Left to Right: Dr. Poon, Dr. Kang, Dr. Ndoh, Dr. Storey, and Dr. Wi at session 7 panel)

Following presentations from Dr. Wi and Dr. Poon, the panel delivered a dynamic discussion on how technology can revolutionize cancer care by making treatment more equitable and effective. “We are generating massive amounts of data across the globe,” Dr. Ndoh said. “But unless we apply that data meaningfully to improve care for underserved populations, we are just reinforcing the same inequities in digital form.” The conversation emphasized the need to implement innovation in ways that reduce, rather than widen, disparities in cancer care delivery.

Later that day, Dr. Ndoh participated in another panel, Session 11 on Building Sustainable Partnerships for Cancer Equity. Drawing on his experience in countries including Rwanda, Kenya, Nigeria, and the United States, he highlighted the critical role of collaboration in closing cancer care gaps both globally and in underserved communities across the U.S. “The only way to truly advance global health initiatives or address disparities is by building lasting partnerships rooted in mutual trust, mutual respect, aligned priorities, and a shared end goal,” he emphasized.

(Left to right: Dr. Anu Agrawal, Dr. Corey Casper, Dr. Ndoh, and Dr. Ashwani Rajput at Session 11)

Dr. Ndoh has led several partnership-driven efforts focused on promoting health equity. Through Hurone AI, he has developed AI-powered digital oncologists to support regions with limited access to cancer specialists and has championed the rapid application of research to practice. His collaborations span academic institutions and hospitals, including Aga Khan University Hospital in Kenya, where digitized medical data is used to train and refine AI systems for cancer care.

These partnerships are designed not only around advanced technology but also around real-world community needs. In countries like Kenya and Rwanda, where many people lack access to smartphones, Hurone AI has created solutions that function through existing platforms such as WhatsApp and USSD. In the United States, Hurone AI partners with academic leaders like the UCSF Brain Tumor Center and Johns Hopkins University to validate and improve AI models, with the goal of extending their use to community health centers.

“Global health starts locally,” Dr. Ndoh said. “There are enormous disparities right here in the U.S. The future of healthcare will be a perfect symbiosis between big data and healthcare providers. Once that is proven, it will become the standard.”

Reflecting on his experience at SCHD25, he shared, “You are sharing knowledge and expertise, and gaining it, too. Meetings like this spark collaborations and create opportunities to network. I connected with Dr. John Kang from Fred Hutch, and we had valuable conversations. I also learned about the work Binaytara is doing, which got me thinking about how I can contribute to initiatives like the one in Nepal and others that are being planned.”

 

About Hurone AI

Hurone AI is a Seattle-based health technology company revolutionizing cancer care through artificial intelligence. Founded by Dr. Kingsley I. Ndoh, Hurone AI develops scalable, explainable AI solutions that enhance clinical decision-making, streamline patient navigation, and improve outcomes, particularly in underserved communities. Its flagship platform, Gukiza, leverages diverse datasets and federated learning to deliver personalized, real-time treatment insights while maintaining the highest standards of privacy and equity. Hurone AI collaborates with leading cancer centers, pharmaceutical companies, and global health organizations to make precision oncology accessible worldwide.

 

About Binaytara

Binaytara is a Bellevue-based nonprofit organization dedicated to reducing cancer health disparities through education, advocacy, research, and clinical care. Founded in 2007 by Dr. Binay Shah and Tara Shah, the foundation operates a 25-bed cancer hospital in Janakpur, Nepal, with plans to expand to a 200-bed facility by 2027. Binaytara also hosts over 50 CME-accredited oncology conferences annually across the United States and has developed innovative tools like the OncoBlast app to enhance oncology education. Through global partnerships and a commitment to equity, Binaytara is transforming cancer care delivery in underserved communities worldwide.

Floria Nyandaya

Research Fellow | Program Manager, Hurone AI

Floria Nyandaya is a physician-scientist dedicated to tackling health disparities in non-communicable diseases(NCDs) amidst Africa’s epidemiological transition. 

With a diverse background in primary clinical practice, healthcare management, infectious disease surveillance and NCD research, she has recently expanded her focus to digital health technologies. As a recipient of the Cardiometabolic Research Fellowship and the Thomas Francis Jr. Global Health Fellowship in her MPH program, Floria gained hands-on global health experience in the U.S., Nigeria, and Kenya. 

Her research endeavors have been multifaceted, from advancing women’s cardiovascular health to exploring the utility of artificial intelligence in enhancing renal and cancer care and addressing diversity gaps in clinical trial research. Continuously driven by her passion for making a tangible difference, Floria remains dedicated to improving the health and well-being of underserved populations.

 
Marko Stanojević

Engineering Product Manager, Hurone AI

Marko is the Engineering Product Manager at Hurone AI. He has a Bachelor of Science in Computer Science from the Belgrade Institute of Technology. His expertise in software engineering and product development plays a key role in Hurone AI’s success.

Marko’s ability to bridge technology and user experience has been vital in driving the launch of Hurone AI’s innovative products. His collaborative approach and adaptability ensure that the company’s solutions meet the highest standards.

Outside of work, Marko is passionate about technology and stays updated on the latest industry trends. His commitment to continuous learning makes him an invaluable asset to the Hurone AI team.